Korro Bio, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $54.5M | $185.4M | $79.6M |
| FY2022 | $8.9M | $73.7M | $36.3M |
| FY2023 | $51.8M | $221.7M | $36.6M |
| FY2024 | $65.8M | $226.2M | $55.6M |
| FY2025 | $62.1M | $113.5M | $21.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $54.5M | $185.4M | $79.6M |
| FY2022 | $8.9M | $73.7M | $36.3M |
| FY2023 | $51.8M | $221.7M | $36.6M |
| FY2024 | $65.8M | $226.2M | $55.6M |
| FY2025 | $62.1M | $113.5M | $21.8M |